May 26, 2016 2:58 AM ET

Pharmaceuticals

Company Overview of Biotie Therapies AG

Company Overview

Biotie Therapies AG provides drug development services focusing on neurology and psychiatry. Its SYN-118 product is a therapy for advanced Parkinson's disease patients. The company also provides clinical development programs and research services. It has a strategic partnership with UCB SA. The company was formerly known as Synosia Therapeutics AG and changed its name to Biotie Therapies AG in February 2011. The company was founded in 2005 and is based in Basel, Switzerland. As of February 2, 2011, Biotie Therapies AG operates as a subsidiary of Biotie Therapies Corp.

Aeschenvorstadt 36

Basel,  4051

Switzerland

Founded in 2005

Phone:

41 61 206 92 02

Fax:

41 61 206 92 01

Key Executives for Biotie Therapies AG

Co-Founder and Chief Medical Advisor
Age: 67
Co-Founder and Chairman of Scientific Advisory Board
Chief Business Advisor
Vice President of Technical Operations
Chief Business Officer
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
AC Immune SA Europe
Acino Holding AG Europe
Albea Pharmaceuticals AG Europe
Alpen Pharma AG Europe
Alpex Pharma SA Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Biotie Therapies AG, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.